Athos Therapeutics, Inc. — Form D

Athos Therapeutics, Inc. of TORRANCE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-06. The offering totals $35.0M, of which $7.6M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2024-02-06
• Form: D
• Accession: 0001885079-24-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $35.0M
• Amount sold: $7.6M
• Remaining: $27.4M
• Investors: 30
• Date of first sale: 2024-01-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-504518

Issuer

• Name: Athos Therapeutics, Inc.
• CIK: 0001885079
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 1123 W. CARSON ST., TORRANCE, CA, 90502
• Phone: 857-222-0410

Officers, directors & promoters (13)

Other filings by this issuer (3)

More

• CIK 1885079 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search